Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Have your say on EU regulation of metal-on-metal hips; consultation ends late April

This article was originally published in Clinica

Executive Summary

The European Commission and the Scientific Committee on Emerging Newly Identified Health Risks (SCENIHR) have launched a public consultation on the latter’s 66-page preliminary opinion on “the safety of metal-on-metal joint replacements with a particular focus on hip implants”. The deadline for written comments from the scientific community and other stakeholders is 25 April.

You may also be interested in...



EU Regulatory Roundup, November 2020: Plenty Of Advice And Guidance As Deadlines Approach

Those marketing products covered under the EU’s MDR and IVD Regulations have plenty of reading this month to help them prepare. More details have also emerged about the UK’s regulatory future.

Notified Body Pain Points: The Challenges And Obstacles Industry Needs To Avoid

Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?

Long-Awaited EU IVD Classification Guidance Just Published: Initial Reactions

The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.

Topics

UsernamePublicRestriction

Register

SC143429

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel